SOAT1 is a new prognostic factor of colorectal cancer

Ir J Med Sci. 2022 Aug;191(4):1549-1554. doi: 10.1007/s11845-021-02746-5. Epub 2021 Aug 30.

Abstract

Colorectal cancer (CRC) is one of the most common malignant gastrointestinal cancers. Metastasis is the major leading cause of death in patients with CRC, and many patients treated with radical surgery were diagnosed with metastasis during follow-up. However, the underlying molecular mechanisms regulating CRC metastasis are still elusive. Sterol o-acyltransferase 1 (SOAT1) is a critical participant in maintaining intracellular cholesterol balance. Here, by analyzing the clinical specimens and in vitro cell line experiments, we evaluated the clinical relevance and role of SOAT1 in regulating CRC metastasis. The results revealed that SOAT1 was overexpressed in colon cancer tissues compared to peritumor tissues at mRNA and protein levels. High intratumor SOAT1 expression correlates to lymph node metastasis and indicates poor patient disease-free survival and overall survival. The silencing of SOAT1 strongly inhibited the migration and invasion ability of CRC tumor cells. These results demonstrated that SOAT1 was upregulated in colon cancer. Upregulation of SOAT1 expression may promote CRC progression by enhancing the migration and invasion ability of CRC. Our results indicate that targeting SOAT1 activity may be applied as a promising therapeutic strategy for preventing the metastasis of CRC after radical surgical treatment.

Keywords: Colorectal cancer; Metastasis; Prognosis; SOAT1.

MeSH terms

  • Biomarkers, Tumor / genetics
  • Cell Line, Tumor
  • Cell Movement
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / genetics
  • Colorectal Neoplasms* / surgery
  • Humans
  • Prognosis
  • Sterol O-Acyltransferase* / genetics

Substances

  • Biomarkers, Tumor
  • Sterol O-Acyltransferase
  • sterol O-acyltransferase 1